These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28487295)

  • 1. Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.
    Allott EH; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    Cancer Prev Res (Phila); 2017 Jun; 10(6):319-326. PubMed ID: 28487295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.
    Moreira DM; Nickel JC; Gerber L; Muller RL; Andriole GL; Castro-Santamaria R; Freedland SJ
    Cancer; 2014 Jan; 120(2):190-6. PubMed ID: 24323568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy.
    Bañez LL; Klink JC; Jayachandran J; Lark AL; Gerber L; Hamilton RJ; Masko EM; Vollmer RT; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):722-8. PubMed ID: 20160265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    Allott EH; Csizmadi I; Howard LE; Muller RL; Moreira DM; Andriole GL; Roehrborn CG; Freedland SJ
    BJU Int; 2020 Feb; 125(2):226-233. PubMed ID: 31479563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: Results from the REDUCE study.
    Moreira DM; Nickel JC; Andriole GL; Castro-Santamaria R; Freedland SJ
    Prostate; 2015 Sep; 75(13):1492-8. PubMed ID: 26184556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
    Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.
    Jamnagerwalla J; Howard LE; Allott EH; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freeman MR; Freedland SJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):252-259. PubMed ID: 29282360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database.
    Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2349-56. PubMed ID: 25304929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database.
    Dambal S; Howard LE; Allott EH; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ
    J Urol; 2020 Jan; 203(1):120-127. PubMed ID: 31430247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both acute and chronic inflammation are associated with less perineural invasion in men with prostate cancer on repeat biopsy.
    Kuang AG; Nickel JC; Andriole GL; Castro-Santamaria R; Freedland SJ; Moreira DM
    BJU Int; 2019 Jan; 123(1):91-97. PubMed ID: 29873889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.
    Stimac G; Reljic A; Spajic B; Dimanovski J; Ruzic B; Ulamec M; Sonicki Z; Kraus O
    Scott Med J; 2009 Aug; 54(3):8-12. PubMed ID: 19725275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
    Murtola TJ; Tammela TL; Määttänen L; Huhtala H; Platz EA; Ala-Opas M; Stenman UH; Auvinen A
    Int J Cancer; 2010 Oct; 127(7):1650-9. PubMed ID: 20073066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer.
    Fowke JH; Motley SS
    Carcinogenesis; 2018 May; 39(6):819-825. PubMed ID: 29617729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina-Louisiana Prostate Cancer Project.
    Allott EH; Farnan L; Steck SE; Arab L; Su LJ; Mishel M; Fontham ET; Mohler JL; Bensen JT
    Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):670-7. PubMed ID: 26819265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.
    Nickel JC; Roehrborn CG; O'leary MP; Bostwick DG; Somerville MC; Rittmaster RS
    J Urol; 2007 Sep; 178(3 Pt 1):896-900; discussion 900-1. PubMed ID: 17632164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
    Gutt R; Tonlaar N; Kunnavakkam R; Karrison T; Weichselbaum RR; Liauw SL
    J Clin Oncol; 2010 Jun; 28(16):2653-9. PubMed ID: 20421534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.
    Moreira DM; Nickel JC; Andriole GL; Castro-Santamaria R; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):180-4. PubMed ID: 26782712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
    Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
    Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and prostate cancer risk: a case-control study.
    Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
    Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.